What is Liquid I.V?
Based in El Segundo, California, Liquid I.V. operates at the intersection of health science and consumer wellness. The company distinguishes itself through the proprietary application of Cellular Transport Technology (CTT), a scientific approach designed to optimize the absorption of hydration and essential nutrients into the bloodstream. By prioritizing non-GMO, clean-label ingredients, the brand has effectively captured a loyal demographic seeking efficient, science-backed alternatives to traditional hydration products. Its market position is defined by a commitment to rapid nutrient delivery, positioning the firm as a leader in the functional nutrition space.
How much funding has Liquid I.V raised?
Liquid I.V has raised a total of $10M across 2 funding rounds:
Series B
$5M
Series A
$5M
Series B (2018): $5M, investors not publicly disclosed
Series A (2018): $5M, investors not publicly disclosed
Key Investors in Liquid I.V
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Liquid I.V?
With this major enterprise-level funding, Liquid I.V. is well-positioned to scale its operational infrastructure and expand its distribution footprint. The strategic deployment of this capital will likely focus on enhancing R&D capabilities to further refine its CTT platform and potentially diversify its product portfolio into adjacent wellness categories. As the company transitions into a more mature growth phase, the focus will shift toward sustaining market share against legacy competitors while maintaining the high-quality standards that have defined its brand identity. Future initiatives will likely prioritize supply chain optimization and aggressive customer acquisition strategies to solidify its dominance in the hydration sector.
See full Liquid I.V company page
